查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600689

Cystatin C檢測法市場：按產品類型、檢測法、樣品類型、設定、應用和最終用戶 - 2025-2030 年全球預測

Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Cystatin C檢測法市值為4.2747億美元，預計到2024年將達到4.5983億美元，複合年成長率為7.24%，預計到2030年將達到6.9741億美元。

Cystatin C檢測法是一種醫學診斷工具，用於測量Cystatin C是一種反映腎功能的蛋白質，可提供比傳統肌酸酐檢測更準確的評估。該測試的必要性在於它能夠提供更快、更準確的有關腎功能下降的資訊，這使得它對於慢性腎臟病(CKD) 監測、心血管風險評估和腎病學研究等應用至關重要。最終用途包括醫院、診斷實驗室和研究機構。慢性腎臟病盛行率的上升、人口老化以及對準確診斷的需求不斷增加正在推動市場發展。影響生長的關鍵因素包括測量技術的進步、腎臟健康意識的提高以及將Cystatin C檢測納入常規健康檢查。最新的機會出現在醫療基礎設施正在改善的新興市場以及由於生活方式因素而導致 CKD 發病率較高的地區。此外，整合遺傳標記和Cystatin C的組合檢測的開發有可能融入個人化醫療的趨勢。

主要市場統計
基準年[2023] 4.2747億美元
預測年份 [2024] 45983萬美元
預測年份 [2030] 6.9741億美元
複合年成長率（%） 7.24%

然而，高成本、新興市場醫療保健專業人員缺乏意識以及由於非標準化測試方法導致測試結果變化等挑戰可能會阻礙市場成長。技術進步等領域需要創新，以降低成本並提高檢查速度和準確性。投資新興市場醫療保健提供者的教育和培訓可以使檢測的好處更加明確和廣泛，從而有可能增加採用率。儘管由於不斷的技術創新和監管挑戰，市場目前競爭激烈且分散，但透過與生物技術公司合作以及專注於可攜式或就地檢驗解決方案，存在擴展的機會。總體而言，擴大早期診斷和慢性病管理的應用可能會維持和加強市場軌跡。

市場動態：快速發展的Cystatin C檢測法市場的關鍵市場洞察

Cystatin C檢測法市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 腎臟疾病盛行率上升和老年人口不斷增加
    • 腎臟病醫療基礎建設投資進展
  • 市場限制因素
    • Cystatin C檢測法開發成本高且發生產品召回
  • 市場機會
    • Cystatin C檢測法測試的進展
    • 開始研究採用Cystatin C檢測法來取代基於肌酸酐的測試
  • 市場挑戰
    • 缺乏熟練的測試專業人員以及與Cystatin C檢測法相關的技術挑戰

波特五力：駕馭Cystatin C檢測法市場的策略工具

波特五力架構是了解Cystatin C檢測法市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解Cystatin C檢測法市場的外部影響

外部宏觀環境因素在塑造Cystatin C檢測法市場的動態動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解Cystatin C檢測法市場的競爭狀況

對Cystatin C檢測法市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣Cystatin C檢測法市場供應商的績效評估

FPNV 定位矩陣是評估Cystatin C檢測法市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類了供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腎臟疾病盛行率上升和老年人口增加
      • 積極投資腎臟疾病醫療基礎設施
    • 抑制因素
      • Cystatin C檢測的開發成本高且產品召回率高
    • 機會
      • Cystatin C檢測法的進展
      • 新研究採用Cystatin C測試取代基於肌酸酐的測試
    • 任務
      • 缺乏熟練的實驗室專業人員以及與Cystatin C檢測法相關的技術挑戰
  • 市場區隔分析
    • 產品：消費者首選的Cystatin C分析儀，用於診斷和狀態監測
    • 方法：擴大酵素結合免疫吸附檢測法(ELISA) 在Cystatin C測定中的應用
    • 背景：擴大Cystatin C檢測在照護現場環境中的使用
    • 樣本類型：尿液樣本，Cystatin C檢測法的關鍵作用是測量樣本中肌酸酐的含量
    • 應用：擴大Cystatin C測定在腎功能診斷的應用
    • 最終用戶：擴大Cystatin C測定在學術研究中心的生物標記研究中的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章Cystatin C檢測法市場：依產品

  • 分析儀
  • 套件
  • 試劑

第7章Cystatin C檢測法市場：依方法分類

  • 化學冷光免疫檢測
  • 酵素免疫分析法
  • 螢光測定
  • 顆粒增強免疫檢測
  • 顆粒增強免疫檢測

第 8 章Cystatin C檢測法市場（依樣本類型）

  • 血
  • 尿

第 9 章Cystatin C檢測法市場設置

  • 實驗室設置
  • 照護現場設置

第 10 章Cystatin C檢測法市場：依應用分類

  • 使用診斷
  • 研究與開發

第 11 章 胱抑素Cystatin C檢測法市場：依最終用戶分類

  • 學術研究中心
  • 診斷實驗室
  • 醫院/診所

第12章 美洲Cystatin C檢測法市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太胱Cystatin C檢測法市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章 歐洲、中東和非洲的Cystatin C檢測法市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Jana Care 融資 600 萬美元用於自我驗血商業化
    • RhodesMed 宣佈在馬哈拉斯特拉邦開設第一個病理中心
    • Renalyse 完成 100 萬歐元資金籌措，GENESIS Ventures 參與
    • Renalytix 選擇 EVERSANA 擴大 KidneyIntelX 的商業化，用於 2 型糖尿病患者腎臟疾病的早期預後檢測
    • 歐洲新的 eGFRCystatin C公式可能更準確
    • Jana Care 與羅氏合作開發和分銷血液檢測平台，以改善慢性腎臟病和心臟病患者的遠距護理
    • Gentian Diagnostics ASA 簽署Cystatin C經銷協議
    • Bloom Diagnostics 宣布新的腎臟測試

公司名單

  • Abbexa Limited
  • Abbott Laboratories
  • Abcam PLC
  • Advy Chemical Pvt. Ltd.
  • Agilent Technologies, Inc.
  • AOBIOUS Inc.
  • Arbor Assays Inc.
  • Aviva Systems Biology Corporation
  • BBI Solutions OEM Limited
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biorbyt Ltd
  • BioVendor-Laboratorni medicina as
  • Boditech Med Inc.
  • Cepham Life Sciences, Inc.
  • Cusabio Technology LLC
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc. by General Atomics
  • Eagle Biosciences, Inc.
  • Elabscience Biotechnology Inc.
  • Ethos Biosciences, Inc.
  • Eurolyser Diagnostica GmbH by Mars, Incorporated
  • F. Hoffmann-La Roche Ltd
  • Fapon Biotech Inc.
  • Fortress Diagnostics Ltd.
  • Gentian Diagnostics ASA
  • Getein Biotech, Inc.
  • ImmunoDiagnostics Limited
  • Kamiya Biomedical Company
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Proteintech Group, Inc.
  • PZ CORMAY SA
  • Randox Laboratories Ltd.
  • RayBiotech, Inc.
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Weldon Biotech
  • Zhejiang Kangte Biotechnology Co., Ltd.
Product Code: MRR-2E76C3E47F4F

The Cystatin C Assay Market was valued at USD 427.47 million in 2023, expected to reach USD 459.83 million in 2024, and is projected to grow at a CAGR of 7.24%, to USD 697.41 million by 2030.

A Cystatin C Assay is a medical diagnostic tool used to measure levels of cystatin C, a protein that reflects kidney function, providing a more accurate assessment than traditional creatinine tests. The necessity of this assay lies in its ability to offer earlier and precise information about declining renal function, making it essential in applications such as chronic kidney disease (CKD) monitoring, cardiovascular risk assessment, and research in nephrology. The end-use scope encompasses hospitals, diagnostic laboratories, and research institutes. The market is primarily driven by the rising prevalence of CKD, an aging population, and increasing demand for accurate diagnostics. Key influencing growth factors include advancements in assay technologies, heightened awareness about kidney health, and the integration of cystatin C testing within routine health check-ups. Latest opportunities are seen in emerging markets where healthcare infrastructure is improving and in regions witnessing a higher incidence of CKD due to lifestyle factors. Additionally, the development of combination assays that integrate genetic markers and cystatin C could tap into personalized medicine trends.

KEY MARKET STATISTICS
Base Year [2023] USD 427.47 million
Estimated Year [2024] USD 459.83 million
Forecast Year [2030] USD 697.41 million
CAGR (%) 7.24%

However, challenges like high costs, lack of awareness among medical professionals in developing regions, and variability in assay results due to non-standardized testing methods can impede market growth. Innovations are necessary in areas such as cost reduction through technological advances and enhancement of assay speed and accuracy. Investing in education and training for healthcare providers in emerging markets could better identify and promote the assay's benefits, broadening its adoption. The market is currently competitive and fragmented, driven by constant innovation and regulatory challenges, but opportunities for expansion exist through collaborations with biotech firms and focus on portable or point-of-care testing solutions. Overall, expanding applications in early diagnosis and chronic disease management will sustain and enhance market trajectory.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystatin C Assay Market

The Cystatin C Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of kidney diseases and growing geriatric population
    • Progressive investments in healthcare infrastructures for renal disorders
  • Market Restraints
    • High development costs of cystatin C assays and incidences of product recalls
  • Market Opportunities
    • Advances in cystatin C assay testing
    • Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
  • Market Challenges
    • Dearth of skilled lab professionals and technical challenges associated with cystatin C assay

Porter's Five Forces: A Strategic Tool for Navigating the Cystatin C Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystatin C Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystatin C Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystatin C Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystatin C Assay Market

A detailed market share analysis in the Cystatin C Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystatin C Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystatin C Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cystatin C Assay Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abbott Laboratories, Abcam PLC, Advy Chemical Pvt. Ltd., Agilent Technologies, Inc., AOBIOUS Inc., Arbor Assays Inc., Aviva Systems Biology Corporation, BBI Solutions OEM Limited, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biorbyt Ltd, BioVendor - Laboratorni medicina a.s., Boditech Med Inc., Cepham Life Sciences, Inc., Cusabio Technology LLC, DIALAB GmbH, DiaSys Diagnostic Systems GmbH, Diazyme Laboratories, Inc. by General Atomics, Eagle Biosciences, Inc., Elabscience Biotechnology Inc., Ethos Biosciences, Inc., Eurolyser Diagnostica GmbH by Mars, Incorporated, F. Hoffmann-La Roche Ltd, Fapon Biotech Inc., Fortress Diagnostics Ltd., Gentian Diagnostics ASA, Getein Biotech, Inc., ImmunoDiagnostics Limited, Kamiya Biomedical Company, Laboratory Corporation of America Holdings, Merck KGaA, Proteintech Group, Inc., PZ CORMAY S.A., Randox Laboratories Ltd., RayBiotech, Inc., Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sino Biological, Inc., Thermo Fisher Scientific Inc., Tosoh Corporation, Weldon Biotech, and Zhejiang Kangte Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystatin C Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Analyzer, Kits, and Reagents.
  • Based on Method, market is studied across Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay, Particle-enhanced Nephelometric Immunoassay, and Particle-enhanced Turbidimetric Immunoassay.
  • Based on Sample Type, market is studied across Blood and Urine.
  • Based on Setting, market is studied across Laboratory Setting and Point of Care Setting.
  • Based on Application, market is studied across Diagnosis Use and Research & Development.
  • Based on End-user, market is studied across Academic Research Centers, Diagnostic Laboratories, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of kidney diseases and growing geriatric population
      • 5.1.1.2. Progressive investments in healthcare infrastructures for renal disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High development costs of cystatin C assays and incidences of product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in cystatin C assay testing
      • 5.1.3.2. Emerging research for adoption of cystatin C assays as alternative to creatinine-based tests
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled lab professionals and technical challenges associated with cystatin C assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Consumer preference cystatin C analyzer for diagnosis and monitoring conditions
    • 5.2.2. Method: Expanding usage of enzyme-linked immunosorbent assay (ELISA) for cystatin C assays
    • 5.2.3. Setting: Expanding usage of point-of-care setting for cystatin C assays
    • 5.2.4. Sample Type: Significant role urine sample for cystatin C assay for measuring the amount of creatinine in a sample
    • 5.2.5. Application: Increasing application of cystatin C assays for diagnosis of renal function
    • 5.2.6. End-user: Expanding usage of cystatin C assays in academic research centers for studying biomarkers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystatin C Assay Market, by Product

  • 6.1. Introduction
  • 6.2. Analyzer
  • 6.3. Kits
  • 6.4. Reagents

7. Cystatin C Assay Market, by Method

  • 7.1. Introduction
  • 7.2. Chemiluminescence Immunoassay
  • 7.3. Enzyme linked Immunosorbent Assay
  • 7.4. Immunofluorescence Assay
  • 7.5. Particle-enhanced Nephelometric Immunoassay
  • 7.6. Particle-enhanced Turbidimetric Immunoassay

8. Cystatin C Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Urine

9. Cystatin C Assay Market, by Setting

  • 9.1. Introduction
  • 9.2. Laboratory Setting
  • 9.3. Point of Care Setting

10. Cystatin C Assay Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnosis Use
  • 10.3. Research & Development

11. Cystatin C Assay Market, by End-user

  • 11.1. Introduction
  • 11.2. Academic Research Centers
  • 11.3. Diagnostic Laboratories
  • 11.4. Hospitals & Clinics

12. Americas Cystatin C Assay Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cystatin C Assay Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cystatin C Assay Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Jana Care Raises USD 6 Million for Commercialisation of Self-Administered Blood Tests
    • 15.3.2. LordsMed Announces the Launch of its First Pathology Centre in Maharashtra
    • 15.3.3. Renalyse Closes a EUR 1 Million Funding Round with the Participation of GENESIS Ventures
    • 15.3.4. Renalytix Selects EVERSANA to Expand Commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
    • 15.3.5. New European Cystatin C Equation for eGFR May Be More Accurate
    • 15.3.6. Jana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
    • 15.3.7. Gentian Diagnostics ASA Signs Distribution Agreement for Cystatin C
    • 15.3.8. Bloom Diagnostics Launches New Kidney Test

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abbott Laboratories
  • 3. Abcam PLC
  • 4. Advy Chemical Pvt. Ltd.
  • 5. Agilent Technologies, Inc.
  • 6. AOBIOUS Inc.
  • 7. Arbor Assays Inc.
  • 8. Aviva Systems Biology Corporation
  • 9. BBI Solutions OEM Limited
  • 10. Bio-Rad Laboratories, Inc.
  • 11. Bio-Techne Corporation
  • 12. Biorbyt Ltd
  • 13. BioVendor - Laboratorni medicina a.s.
  • 14. Boditech Med Inc.
  • 15. Cepham Life Sciences, Inc.
  • 16. Cusabio Technology LLC
  • 17. DIALAB GmbH
  • 18. DiaSys Diagnostic Systems GmbH
  • 19. Diazyme Laboratories, Inc. by General Atomics
  • 20. Eagle Biosciences, Inc.
  • 21. Elabscience Biotechnology Inc.
  • 22. Ethos Biosciences, Inc.
  • 23. Eurolyser Diagnostica GmbH by Mars, Incorporated
  • 24. F. Hoffmann-La Roche Ltd
  • 25. Fapon Biotech Inc.
  • 26. Fortress Diagnostics Ltd.
  • 27. Gentian Diagnostics ASA
  • 28. Getein Biotech, Inc.
  • 29. ImmunoDiagnostics Limited
  • 30. Kamiya Biomedical Company
  • 31. Laboratory Corporation of America Holdings
  • 32. Merck KGaA
  • 33. Proteintech Group, Inc.
  • 34. PZ CORMAY S.A.
  • 35. Randox Laboratories Ltd.
  • 36. RayBiotech, Inc.
  • 37. Sekisui Diagnostics, LLC
  • 38. Siemens Healthineers AG
  • 39. Sino Biological, Inc.
  • 40. Thermo Fisher Scientific Inc.
  • 41. Tosoh Corporation
  • 42. Weldon Biotech
  • 43. Zhejiang Kangte Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CYSTATIN C ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTATIN C ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 26. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTATIN C ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTATIN C ASSAY MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. CYSTATIN C ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ANALYZER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED NEPHELOMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY LABORATORY SETTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY POINT OF CARE SETTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSIS USE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY ACADEMIC RESEARCH CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 28. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CYSTATIN C ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 30. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 31. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 34. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 35. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 36. AMERICAS CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 37. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 38. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 39. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 40. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 41. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 42. ARGENTINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 43. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 44. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 45. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 46. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 47. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 48. BRAZIL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 49. CANADA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 50. CANADA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 51. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 52. CANADA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 53. CANADA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 54. CANADA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 55. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 56. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 57. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 58. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 59. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 60. MEXICO CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 61. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 62. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 63. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 64. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 65. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 66. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 67. UNITED STATES CYSTATIN C ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 68. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 69. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 70. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 71. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 72. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 73. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 74. ASIA-PACIFIC CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 75. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 76. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 77. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 78. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 79. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 80. AUSTRALIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 81. CHINA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 82. CHINA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 83. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 84. CHINA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 85. CHINA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 86. CHINA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 87. INDIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 88. INDIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 89. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 90. INDIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 91. INDIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 92. INDIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 93. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 94. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 95. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 96. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 97. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 98. INDONESIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 99. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 100. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 101. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 102. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 103. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 104. JAPAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 105. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 106. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 107. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 108. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 109. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 110. MALAYSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 111. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 112. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 113. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 114. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 115. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 116. PHILIPPINES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 117. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 118. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 119. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 120. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 121. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 122. SINGAPORE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 123. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 124. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 125. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 126. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 127. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 128. SOUTH KOREA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 129. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 130. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 131. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 132. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 133. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 134. TAIWAN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 135. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 136. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 137. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 138. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 139. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 140. THAILAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 141. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 142. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 143. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 144. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 145. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 146. VIETNAM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CYSTATIN C ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 154. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 155. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 156. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 157. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 158. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 159. DENMARK CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 160. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 161. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 162. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 163. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 164. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 165. EGYPT CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 166. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 167. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 168. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 169. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 170. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 171. FINLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 172. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 173. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 174. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 175. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 176. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 177. FRANCE CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 178. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 179. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 180. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 181. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 182. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 183. GERMANY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 184. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 185. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 186. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 187. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 188. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 189. ISRAEL CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 190. ITALY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 191. ITALY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 192. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 193. ITALY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 194. ITALY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 195. ITALY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 196. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 197. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 198. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 199. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 200. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 201. NETHERLANDS CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 202. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 203. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 204. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 205. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 206. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 207. NIGERIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 208. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 209. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 210. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 211. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 212. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 213. NORWAY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 214. POLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 215. POLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 216. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 217. POLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 218. POLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 219. POLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 220. QATAR CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 221. QATAR CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 222. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 223. QATAR CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 224. QATAR CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 225. QATAR CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 226. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 227. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 228. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 229. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 230. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 231. RUSSIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 232. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 233. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 234. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 235. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 236. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 237. SAUDI ARABIA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 238. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 239. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 240. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 241. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 242. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 243. SOUTH AFRICA CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 244. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 245. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 246. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 247. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 248. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 249. SPAIN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 250. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 251. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 252. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 253. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 254. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 255. SWEDEN CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 256. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 257. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 258. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 259. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 260. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 261. SWITZERLAND CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 262. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 263. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 264. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 265. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 266. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 267. TURKEY CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 268. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 269. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 270. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 271. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 272. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 273. UNITED ARAB EMIRATES CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 274. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 275. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY METHOD, 2018-2030 (USD THOUSAND)
  • TABLE 276. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 277. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY SETTING, 2018-2030 (USD THOUSAND)
  • TABLE 278. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 279. UNITED KINGDOM CYSTATIN C ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 280. CYSTATIN C ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. CYSTATIN C ASSAY MARKET, FPNV POSITIONING MATRIX, 2023